Brussels, 08/03/2013 (Agence Europe) - On Thursday 7 March, the European Union decided to submit the new drug, 4-methylamphetamine (4-MA), to control measures and criminal penalties, an EMCDDA (European Monitoring Centre on Drugs and Drug Addiction) press release states. The decision is based on the conclusions of a formal risk assessment report on 4-MA, drafted in 2012 by the extended Scientific Committee of the EMCDDA, with the participation of additional experts from the EU member states,...